AF
HCAT icon

Avanza Fonder’s Health Catalyst HCAT Stock Holding History

Avanza Fonder’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.1K Hold
26,050
– – ﹤0.01% 481
2025
Q4 		$62.3K Hold
26,050
– – ﹤0.01% 487
2025
Q3 		$74.2K Hold
26,050
– – ﹤0.01% 421
2025
Q2 		$98.2K Hold
26,050
– – ﹤0.01% 412
2025
Q1 		$116K Hold
26,050
– – ﹤0.01% 429
2024
Q4 		$184K Buy
+26,050
New +$207K 0.01% 399

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return